Bionano Genomics Inc
BNGO3.035USD
+0.085+2.88%
交易中 （美東）報價延遲15分鐘
9.41M總市值
虧損本益比TTM
關於 Bionano Genomics Inc 公司
Bionano Genomics, Inc. 是一家基因組學公司。該公司提供光學基因組圖譜 (OGM) 解決方案，適用於基礎研究、轉化研究和臨牀研究。通過 Lineagen, Inc.，該公司還爲臨牀表現與自閉症譜系障礙和其他神經發育障礙一致的患者提供診斷測試。它還提供與平臺無關的軟件解決方案，該解決方案集成了測序和微陣列數據，旨在通過一個綜合視圖提供對整個基因組的拷貝數變異、單核苷酸變異和雜合性缺失的分析、可視化、解釋和報告。該公司還使用專有的等速電泳 (ITP) 技術提供核酸提取和純化解決方案。該公司營銷和銷售 OGM 系統，包括 Saphyr 系統，該系統提供 OGM 數據，以實現對所有類別的結構變異 (SV) 的超靈敏和超特異性檢測。
公司簡介
公司代碼BNGO
公司名稱Bionano Genomics Inc
上市日期Aug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.
員工數量98
證券類型Ordinary Share
年結日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編92121
電話18588887600
網址https://bionano.com/
公司代碼BNGO
上市日期Aug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
441.00
-5.77%
Mark Adamchak
Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
441.00
-5.77%
Mark Adamchak
Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
業務USD
名稱
營收
佔比
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
地區USD
名稱
營收
佔比
EMEIA
3.07M
47.48%
Americas
3.06M
47.36%
Asia Pacific
333.00K
5.16%
業務
地區
業務USD
名稱
營收
佔比
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
股東統計
更新時間: 7月24日 週四
更新時間: 7月24日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Heights Capital Management, Inc.
4.69%
The Vanguard Group, Inc.
1.49%
Everstar Asset Management LLC
1.34%
GSA Capital Partners LLP
1.19%
Geode Capital Management, L.L.C.
0.46%
Other
90.83%
持股股東
持股股東
佔比
Heights Capital Management, Inc.
4.69%
The Vanguard Group, Inc.
1.49%
Everstar Asset Management LLC
1.34%
GSA Capital Partners LLP
1.19%
Geode Capital Management, L.L.C.
0.46%
Other
90.83%
股東類型
持股股東
佔比
Investment Advisor
8.32%
Hedge Fund
1.19%
Investment Advisor/Hedge Fund
0.47%
Research Firm
0.33%
Individual Investor
0.06%
Bank and Trust
0.02%
Other
89.62%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
193
349.15K
10.38%
-67.10K
2025Q1
262
309.73K
9.24%
-123.47K
2024Q4
284
105.26K
3.91%
-124.97K
2024Q3
298
94.17K
6.55%
-135.04K
2024Q2
310
116.15K
9.81%
-164.95K
2024Q1
318
86.19K
9.42%
-64.99K
2023Q4
324
107.44K
14.24%
-23.70K
2023Q3
345
94.81K
16.11%
-27.58K
2023Q2
356
93.86K
18.29%
-63.50K
2023Q1
366
141.65K
27.72%
-15.82K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Heights Capital Management, Inc.
157.93K
4.69%
-20.40K
-11.44%
Mar 31, 2025
The Vanguard Group, Inc.
49.98K
1.49%
+18.64K
+59.50%
Mar 31, 2025
Everstar Asset Management LLC
44.98K
1.34%
+44.98K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
15.51K
0.46%
-1.12K
-6.75%
Mar 31, 2025
Parametric Portfolio Associates LLC
11.49K
0.34%
+11.49K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
10.10K
0.3%
-4.00
-0.04%
Mar 31, 2025
BofA Global Research (US)
8.39K
0.25%
+8.37K
+41865.00%
Mar 31, 2025
Osaic Holdings, Inc.
3.21K
0.1%
+3.03K
+1722.73%
Mar 31, 2025
UBS Financial Services, Inc.
1.91K
0.06%
-22.00
-1.14%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Dimensional US Core Equity 1 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
SPDR S&P Kensho New Economies Composite ETF
0%
Global X Genomics & Biotechnology ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Genomics Immunology and Healthcare ETF
0%
Global X HealthTech ETF
0%
Dimensional US Core Equity 1 ETF
佔比0%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
SPDR S&P Kensho New Economies Composite ETF
佔比0%
Global X Genomics & Biotechnology ETF
佔比0%
Invesco RAFI US 1500 Small-Mid ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Genomics Immunology and Healthcare ETF
佔比0%
Global X HealthTech ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
公告日期
類型
比率
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
